Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,

Similar presentations


Presentation on theme: "Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,"— Presentation transcript:

1 Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD, Judson B. Williams, MD, Eric Yow, MS, Linda K. Shaw, MS, Kerry L. Lee, PhD, Harry R. Phillips, MD, Christopher M. O'Connor, MD, Peter K. Smith, MD, Robert H. Jones, MD  The Annals of Thoracic Surgery  Volume 93, Issue 2, Pages (February 2012) DOI: /j.athoracsur Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Identification of study cohort from all patients undergoing cardiac catheterization at Duke Medical Center January 1, 1995, through July 31, 2009, and treated with medical therapy (MED) or coronary artery bypass grafting (CABG). (CAD = coronary artery disease; CCS = Canadian Cardiovascular Society; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Propensity quintiles for selecting medical therapy (MED) at Duke 1995–2005. Total patients and mortality are presented for each quintile. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Unadjusted Kaplan-Meier estimates of time to death in all study patients (propensity quintiles I–V). (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Unadjusted (A) and risk-adjusted (B) Kaplan-Meier rate estimates of time to death in 395 patients with similar propensity (quintiles I–III) for medical therapy. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Unadjusted Kaplan-Meier rate estimates of time to death for Surgical Treatment for Ischemic Heart Failure (STICH) trial and Duke Databank for Cardiovascular Disease (DDCD) patients. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,"

Similar presentations


Ads by Google